Clinical trial
Transcranial Magnetic Stimulation (TMS) for Pain Associated With Chronic Fatigue Syndrome/Primary Fibromyalgia, Long COVID and Post-vaccination Syndromes, Post-stroke Pain, and Non-nociceptive Pain
NCT07888673 is registered in ClinicalTrials.gov with Hospital Donostia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcranial Magnetic Stimulation (TMS) for Pain Associated With Chronic Fatigue Syndrome/Primary Fibromyalgia, Long COVID and Post-vaccination Syndromes, Post-stroke Pain, and Non-nociceptive Pain
- Lead sponsor
- Hospital Donostia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2025
- Completion date
- June 1, 2026
- Enrollment
- 47 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, fibromyalgia, long covid19, stroke sequelae
Arms
As registered; 2 arms.
-
Control group
Active and control group . Active group received treatment. Control group did not received treatment
-
Active group
TMS
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Number of adverse effects
Safety and adverse effects
Lead sponsor's other trials
Hospital Donostia, most recent start first.
+5 more trials
Similar trials
Same condition (Nociplastic Pain) and phase, most recent start first.
+9 more trials See the condition page